Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mRNA-3704 in Patients With Isolated Methylmalonic Acidemia
NCT03810690Phase 2Withdrawn
- Sponsor
- Moderna Inc
- Start
- May 2019
- Primary completion
- Aug 2020
- Modality
- Lipid-based Nanoparticles, mRNA Therapeutics
01
Overview
A Phase 2 trial of mRNA-3704 in methylmalonic acidemia (MMA), sponsored by Moderna Inc. Planned start May 2019; status: withdrawn.
02
Drugs
mRNA-3704
03
Conditions
methylmalonic acidemia (MMA)
Beyond the preview
Go deeper on NCT03810690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03810690.